Peripheral Neuropathy Trial, Recruiting (NCT06962579)

Peripheral Neuropathy Trial, Recruiting NCT06962579 Sponsor: Universiteit Antwerpen Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06962579 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have a primary diagnosis of breast, gynaecological, or colon cancer that has not spread to distant parts of the body
People who have not yet received chemotherapy
People who have been scheduled to receive at least 12 weeks of a taxane- or platinum-based chemotherapy treatment, without any other chemotherapy that can affect the nerves

Who may not be able to join:

People whose oncologist estimates their life expectancy to be less than six months
People whose cancer is at an advanced stage
People who currently have a known condition affecting their nerves (neuropathy)
People whose oncologist determines that physical or cognitive limitations make it unsafe for them to take part in a low- to moderate-intensity home-based walking and resistance exercise program
People who are not able to read and understand Dutch
People who are not able to give informed consent to participate
People who are not able to take part for the full duration of the study
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 3 265 16 59

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06962579

Sponsor: Universiteit Antwerpen

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +32 3 265 16 59

More information: https://clinicaltrials.gov/study/NCT06962579

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have a primary diagnosis of breast, gynaecological, or colon cancer that has not spread to distant parts of the body
People who have not yet received chemotherapy
People who have been scheduled to receive at least 12 weeks of a taxane- or platinum-based chemotherapy treatment, without any other chemotherapy that can affect the nerves

Who may not be able to join:

People whose oncologist estimates their life expectancy to be less than six months
People whose cancer is at an advanced stage
People who currently have a known condition affecting their nerves (neuropathy)
People whose oncologist determines that physical or cognitive limitations make it unsafe for them to take part in a low- to moderate-intensity home-based walking and resistance exercise program
People who are not able to read and understand Dutch
People who are not able to give informed consent to participate
People who are not able to take part for the full duration of the study
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universiteit Antwerpen

Registry

ClinicalTrials.gov

Start date

5 June 2025

Est. completion

1 July 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Chemotherapy-induced peripheral neuropathy (CIPN) sensory symptom severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov